Trial Profile
Clinical Trials Insight: 700029022
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2007
Price :
$35
*
At a glance
- Drugs Rifamycin (Primary)
- Indications Clostridium difficile infections; Diarrhoea
- Focus Therapeutic Use
- Sponsors Cosmo Pharmaceuticals
- 03 Dec 2007 New trial record.